Connect with us


Digital healthcare company launches behavioural therapy platform to help Americans in need



The digital healthcare company ShareMy.Health has launched a collaborative care platform to improve behavioural health and provide resources to more than 100 million Americans in need.

The platform integrates therapy, data science, personalised content and clinical tools and connects individuals providers, family, and support circle to extend therapy and improve engagement.

Worldwide, levels of stress, anxiety and depression have soared since the pandemic, costing organisations 12 billion workdays a year, according to the World Health Organization.

With one billion people worldwide now living with mental distress and hospital emergency room visits increasing from issues related to behavioural health, new teletherapy solutions and apps have flooded the market.

Most of these apps are force-rigid teletherapy, limiting the choice of provider and offering little interoperability.

This results in a disjointed experience — leading to app fatigue, low usage, and high cost. Lacking analytics for measurement, very few of these apps present an individual’s status, progress and value of care being received.

“Behavioural health is very complex and attempts to treat it can’t focus solely on siloed therapy, self-care, medication management and technology solutions,” said Galen Murdock, founder and CEO of ShareMy.Health.

“Successful solutions that integrate behavioural health treatment with digital tools will always complement each other and never lessen the hands-on care from a provider that is absolutely essential for a successful health outcome.”

ShareMy.Health (SMH) has previously developed a platform for electronic, medical-record sharing based on a proprietary healthcare privacy architecture.

The new SMH Mental Wellbeing platform aims to make in-person care and applications accessible for the 100 million-plus Americans who suffer from the most common behavioural health issues, such as anxiety, stress, depression, and substance-use disorder.

The developers say the platform powers personalised care by connecting patients, providers, family and peer support communities, while using analytics and AI to enable timely interventions and better treatment over time.

“The cost of depression alone is massive and difficult to understand; it costs US employers up to US$44bn a year in lost productivity,” said Paul Gulbin, chief commercial officer at ShareMy.Health.

“Delaying treatment for mental health conditions can also quadruple the annual cost of medical health claims.

“There are many apps in the marketplace but no real integrated experience across the patient journey. Everyone wants to know if we’re making progress, but visibility to measure and personalise treatment plans has been limited.

“ShareMy.Health now provides full understanding of the patient’s status, progress and benefit over time with ability to measure ROI.”


Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories